In our previous study, we demonstrated that microglial Dlg1 is a regulator of NF-κB signaling, and Dlg1 deletion inhibits microglial activation and inflammatory cytokine production, thereby alleviating LPS-induced depression behavior (Peng et al., 2021). Here, DLG1 is linked to depressive disorder.